44 related articles for article (PubMed ID: 19372779)
1. Role of HIV-1-specific CD4 T cells.
Harari A; Cellerai C; Pantaleo G
Curr Opin HIV AIDS; 2006 Jan; 1(1):22-7. PubMed ID: 19372779
[TBL] [Abstract][Full Text] [Related]
2. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
[TBL] [Abstract][Full Text] [Related]
3. Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure.
Correa R; Harari A; Vallelian F; Resino S; Munoz-Fernandez MA; Pantaleo G
AIDS; 2007 Jan; 21(1):23-30. PubMed ID: 17148964
[TBL] [Abstract][Full Text] [Related]
4. Functional signatures of protective antiviral T-cell immunity in human virus infections.
Harari A; Dutoit V; Cellerai C; Bart PA; Du Pasquier RA; Pantaleo G
Immunol Rev; 2006 Jun; 211():236-54. PubMed ID: 16824132
[TBL] [Abstract][Full Text] [Related]
5. Phenotype and function of protective T cell immune responses in HIV.
Betts MR; Harari A
Curr Opin HIV AIDS; 2008 May; 3(3):349-55. PubMed ID: 19372989
[TBL] [Abstract][Full Text] [Related]
6. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.
Jansen CA; Piriou E; De Cuyper IM; van Dort K; Lange JM; Miedema F; van Baarle D
Antivir Ther; 2006; 11(1):105-16. PubMed ID: 16518966
[TBL] [Abstract][Full Text] [Related]
7. Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy.
Haslett PA; Nixon DF; Shen Z; Larsson M; Cox WI; Manandhar R; Donahoe SM; Kaplan G
J Infect Dis; 2000 Apr; 181(4):1264-72. PubMed ID: 10751137
[TBL] [Abstract][Full Text] [Related]
8. Association between Nef-specific CD8 T-cell responses and disease progression in HIV-1 subtype B infection.
Jiao Y; Li TS; Xie J; Han Y; Qiu ZF; Zuo LY; Mourez T; Wang AX
Chin Med J (Engl); 2006 Oct; 119(19):1609-15. PubMed ID: 17042973
[TBL] [Abstract][Full Text] [Related]
9. Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates.
Mooij P; Balla-Jhagjhoorsingh SS; Koopman G; Beenhakker N; van Haaften P; Baak I; Nieuwenhuis IG; Kondova I; Wagner R; Wolf H; Gómez CE; Nájera JL; Jiménez V; Esteban M; Heeney JL
J Virol; 2008 Mar; 82(6):2975-88. PubMed ID: 18184713
[TBL] [Abstract][Full Text] [Related]
10. New paradigms for generating effective CD8+ T cell responses against HIV-1/AIDS.
Ahlers JD; Belyakov IM
Discov Med; 2010 Jun; 9(49):528-37. PubMed ID: 20587342
[TBL] [Abstract][Full Text] [Related]
11. Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection.
Carcelain G; Tubiana R; Samri A; Calvez V; Delaugerre C; Agut H; Katlama C; Autran B
J Virol; 2001 Jan; 75(1):234-41. PubMed ID: 11119593
[TBL] [Abstract][Full Text] [Related]
12. Innate gamma/delta T-cells during HIV infection: Terra relatively Incognita in novel vaccination strategies?
Agrati C; D'Offizi G; Gougeon ML; Malkovsky M; Sacchi A; Casetti R; Bordoni V; Cimini E; Martini F
AIDS Rev; 2011; 13(1):3-12. PubMed ID: 21412385
[TBL] [Abstract][Full Text] [Related]
13. T-cell responses in primary HIV-1 infection.
Streeck H; van Bockel D; Kelleher A
Curr Opin HIV AIDS; 2008 Jan; 3(1):52-9. PubMed ID: 19372944
[TBL] [Abstract][Full Text] [Related]
14. MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays.
Kutscher S; Allgayer S; Dembek CJ; Bogner JR; Protzer U; Goebel FD; Erfle V; Cosma A
Gene Ther; 2010 Nov; 17(11):1372-83. PubMed ID: 20535218
[TBL] [Abstract][Full Text] [Related]
15. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
McNeil AC; Shupert WL; Iyasere CA; Hallahan CW; Mican JA; Davey RT; Connors M
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13878-83. PubMed ID: 11717444
[TBL] [Abstract][Full Text] [Related]
16. Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection.
Lacabaratz-Porret C; Urrutia A; Doisne JM; Goujard C; Deveau C; Dalod M; Meyer L; Rouzioux C; Delfraissy JF; Venet A; Sinet M
J Infect Dis; 2003 Mar; 187(5):748-57. PubMed ID: 12599048
[TBL] [Abstract][Full Text] [Related]
17. Treatment interruption to boost specific HIV immunity in acute infection.
Kaufmann DE; Walker BD
Curr Opin HIV AIDS; 2007 Jan; 2(1):21-5. PubMed ID: 19372861
[TBL] [Abstract][Full Text] [Related]
18. Qualitative host factors associated with immunological control of HIV infection by CD8 T cells.
Migueles SA; Tilton JC; Connors M
Curr Opin HIV AIDS; 2006 Jan; 1(1):28-33. PubMed ID: 19372780
[TBL] [Abstract][Full Text] [Related]
19. Capturing viral diversity for in-vitro test reagents and HIV vaccine immunogen design.
Brander C; Self S; Korber B
Curr Opin HIV AIDS; 2007 May; 2(3):183-8. PubMed ID: 19372885
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on interleukin-7 therapy in HIV infection.
Lelièvre JD; Lévy Y
Curr Opin HIV AIDS; 2007 May; 2(3):228-33. PubMed ID: 19372891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
